arbutin and 7-hydroxycoumarin

arbutin has been researched along with 7-hydroxycoumarin* in 2 studies

Reviews

2 review(s) available for arbutin and 7-hydroxycoumarin

ArticleYear
Effects of Itxasol© Components on Gene Expression in Bacteria Related to Infections of the Urinary Tract and to the Inflammation Process.
    International journal of molecular sciences, 2021, Nov-23, Volume: 22, Issue:23

    Urinary tract infections (UTIs) represent a health problem of the first magnitude since they affect large segments of the population, cause increased mortality and comorbidity, and have a high incidence of relapse. Therefore, UTIs cause a major socioeconomic concern. Current antibiotic treatments have various limitations such as the appearance of resistance to antibiotics, nephrotoxicity, and side effects such as gastrointestinal problems including microbiota alterations that contribute to increasing antibiotic resistance. In this context, Itxasol© has emerged, approved as an adjuvant for the treatment of UTIs. Designed with biomimetic principles, it is composed of arbutin, umbelliferon, and N-acetyl cysteine. In this work, we review the activities of these three compounds concerning the changes they produce in the expression of bacterial genes and those related to inflammation as well as assess how they are capable of affecting the DNA of bacteria and fungi.

    Topics: Acetylcysteine; Anti-Bacterial Agents; Arbutin; Bacteria; Bacterial Proteins; Drug Combinations; Gene Expression Regulation, Bacterial; Humans; Molecular Mimicry; Umbelliferones; Urinary Tract Infections

2021
A Natural Alternative Treatment for Urinary Tract Infections: Itxasol©, the Importance of the Formulation.
    Molecules (Basel, Switzerland), 2021, Jul-28, Volume: 26, Issue:15

    Genito-urinary tract infections have a high incidence in the general population, being more prevalent among women than men. These diseases are usually treated with antibiotics, but very frequently, they are recurrent and lead to the creation of resistance and are associated with increased morbidity and mortality. For this reason, it is necessary to develop new compounds for their treatment. In this work, our objective is to review the characteristics of the compounds of a new formulation called Itxasol© that is prescribed as an adjuvant for the treatment of UTIs and composed of β-arbutin, umbelliferon and n-acetyl cysteine. This formulation, based on biomimetic principles, makes Itxasol© a broad-spectrum antibiotic with bactericidal, bacteriostatic and antifungal properties that is capable of destroying the biofilm and stopping its formation. It also acts as an anti-inflammatory agent, without the adverse effects associated with the recurrent use of antibiotics that leads to renal nephrotoxicity and other side effects. All these characteristics make Itxasol© an ideal candidate for the treatment of UTIs since it behaves like an antibiotic and with better characteristics than other adjuvants, such as D-mannose and cranberry extracts.

    Topics: Acetylcysteine; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antifungal Agents; Arbutin; Biofilms; Biological Products; Biomimetic Materials; Candida; Drug Combinations; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Microbial Sensitivity Tests; Umbelliferones; Urinary Tract Infections

2021